Medtronic Cardioblate
This article was originally published in The Gray Sheet
Executive Summary
Surgical radiofrequency "pen" system gains FDA market go-ahead for general ablation of cardiac tissue to neutralize "troublesome electrical activity," firm announces Jan. 29. The device incorporates delivery of an electrolytic irrigation solution to cool the outer tissue and allow deeper heat penetration to improve ablation effectiveness, company explains. Medtronic plans to pursue a specific indication for chronic atrial fibrillation with the "Maze" procedure later this year...